BIOMAT Database Logo BIOMAT Database Logo

[Problems and therapy of L-DOPA-induced dyskinesias]. 1972

G W Völler, and J Deze, and U Gundlach, and F Muschard

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009069 Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. Dyskinesia Syndromes,Etat Marbre,Status Marmoratus,Movement Disorder Syndromes,Dyskinesia Syndrome,Movement Disorder,Movement Disorder Syndrome
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G W Völler, and J Deze, and U Gundlach, and F Muschard
Pathophysiology of L-dopa-induced dyskinesias.
January 1999, Movement disorders : official journal of the Movement Disorder Society,
G W Völler, and J Deze, and U Gundlach, and F Muschard
Mirtazapine in L-dopa-induced dyskinesias.
January 2003, Clinical neuropharmacology,
G W Völler, and J Deze, and U Gundlach, and F Muschard
A unified dyskinesias rating scale for L-dopa-induced dyskinesias?
January 1999, Movement disorders : official journal of the Movement Disorder Society,
G W Völler, and J Deze, and U Gundlach, and F Muschard
L-dopa induced dyskinesias in asymmetrical parkinsonism.
January 1979, Acta neurologica latinoamericana,
G W Völler, and J Deze, and U Gundlach, and F Muschard
Surgical approach to l-dopa-induced dyskinesias.
January 2011, International review of neurobiology,
G W Völler, and J Deze, and U Gundlach, and F Muschard
[Physiopathology of the dyskinesias induced by L-dopa].
August 1997, Revista de neurologia,
G W Völler, and J Deze, and U Gundlach, and F Muschard
[Dyskinesias induced by L-DOPA in Parkinson patients].
January 1985, Archivos de neurobiologia,
G W Völler, and J Deze, and U Gundlach, and F Muschard
L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa history.
August 2015, Brain research,
G W Völler, and J Deze, and U Gundlach, and F Muschard
Plasticity, genetics, and epigenetics in l-dopa-induced dyskinesias.
January 2022, Handbook of clinical neurology,
G W Völler, and J Deze, and U Gundlach, and F Muschard
Response of tardive and L-dopa-induced dyskinesias to antidepressants.
November 1987, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
Copied contents to your clipboard!